Preview: Genmab's Earnings

Benzinga42分前

Revitope Oncology Signs License Agreement Providing Genmab A/S Access To Revitope's Conditional TCE Technology, TwoGATE; Revitope Oncology To Receive Upfront Payment Of $9M With Milestone And Fee Payments Up To $600M Plus Tiered Single-Digit Royalties...

Benzinga10/30 01:21

Revitope Enters Into a License Agreement for Next-generation T Cell Engagement Technology

PR Newswire10/30 01:15

Genmab A/S (GMAB): Leading Innovation in Antibody Therapeutics

Yahoo Finance10/17 20:57

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock?

Barchart10/16 22:46

Genmab Analyst Ratings

Benzinga10/16 19:09